Received: 14 December 2018
Accepted: 19 November 2019
First Online: 3 December 2019
Ethics approval and consent to participate
: This study was approved by Research and Ethics Committee of Riphah Institute of Pharmaceutical Sciences (Ref. no. REC/RIPS/2017/008). However, no consent was needed for this study.
: All co-authors have consented for the publication of this manuscript.
: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.